blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1200117

EP1200117 - LIPOPROTEIN LIPASE (LPL) VARIANT THERAPEUTICS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.06.2009
Database last updated on 30.07.2024
Most recent event   Tooltip19.06.2009No opposition filed within time limitpublished on 22.07.2009  [2009/30]
Applicant(s)For all designated states
THE UNIVERSITY OF BRITISH COLUMBIA
IRC Building, Room 331, 2194 Health Sciences Mall Vancouver
British Columbia V6T 1Z3 / CA
For all designated states
Amsterdam Molecular Therapeutics B.V.
Meibergdreef 62
1105 BA Amsterdam / NL
[2008/33]
Former [2007/32]For all designated states
THE UNIVERSITY OF BRITISH COLUMBIA
Office of Research Services and Industry Liaison, Room 331, I.R.C. Building, 2194 Health Sciences Mall
Vancouver, British Columbia V6T 1Z3 / CA
For all designated states
Amsterdam Molecular Therapeutics B.V.
Meibergdreef 62
1105 BA Amsterdam / NL
Former [2002/18]For all designated states
THE UNIVERSITY OF BRITISH COLUMBIA
Office of Research Services and Industry Liaison, Room 331, I.R.C. Building, 2194 Health Sciences Mall
Vancouver, British Columbia V6T 1Z3 / CA
For all designated states
Amsterdam Molecular Therapeutics B.V. (AMT)
Meibergdreef 61
1105 BA Amsterdam / NL
For all designated states
Academic Hospital at the University of Amsterdam
Meibergdreef 61
1105 AZ Amsterdam / NL
Inventor(s)01 / HAYDEN, Michael, R.
4464 West 7th Avenue
Vancouver, British Columbia V6R 1W9 / CA
02 / KASTELEIN, John, J., P.
Hauwert 141
NL-1691 EE Hauwert / NL
03 / EXCOFFON, Katherine Julia Diane Ashbourne
3441 Hillandale Road
Davenport IA 52806 / US
 [2003/01]
Former [2002/18]01 / HAYDEN, Michael, R.
4464 West 7th Avenue
Vancouver, British Columbia V6R 1W9 / CA
02 / KASTELEIN, John, J., P.
Hauwert 141
NL-1691 EE Hauwert / NL
Representative(s)van Westenbrugge, Andries, et al
Nederlandsch Octrooibureau
P.O. Box 29720
NL-2502 LS The Hague / NL
[N/P]
Former [2008/22]van Westenbrugge, Andries, et al
Postbus 29720
2502 LS Den Haag / NL
Former [2003/16]van Westenbrugge, Andries, et al
Nederlandsch Octrooibureau P.O. Box 29720
2502 LS The Hague / NL
Former [2002/18]Jorritsma, Ruurd
Nederlandsch Octrooibureau Scheveningseweg 82 P.O. Box 29720
2502 LS Den Haag / NL
Application number, filing date00943499.423.06.2000
[2002/18]
WO2000CA00762
Priority number, dateEP1999020204824.06.1999         Original published format: EP 99202048
[2002/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0100220
Date:04.01.2001
Language:EN
[2001/01]
Type: A2 Application without search report 
No.:EP1200117
Date:02.05.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 04.01.2001 takes the place of the publication of the European patent application.
[2002/18]
Type: B1 Patent specification 
No.:EP1200117
Date:13.08.2008
Language:EN
[2008/33]
Search report(s)International search report - published on:EP12.07.2001
ClassificationIPC:A61K38/46, A61K48/00, C12N15/63, A61P9/10, // C12N9/20
[2002/18]
CPC:
C12N9/20 (EP,US); A61P3/04 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP); C12Y301/01034 (EP,US);
A61K38/00 (EP,US); A61K48/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/18]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:THERAPIE MIT LIPOPROTEINLIPASE (LPL) VARIANT[2002/18]
English:LIPOPROTEIN LIPASE (LPL) VARIANT THERAPEUTICS[2002/18]
French:TRAITEMENT A BASE DE VARIANTS DE LPL[2002/18]
Entry into regional phase24.01.2002National basic fee paid 
24.01.2002Designation fee(s) paid 
24.01.2002Examination fee paid 
Examination procedure12.01.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.01.2002Amendment by applicant (claims and/or description)
24.01.2002Examination requested  [2002/18]
06.06.2002Despatch of a communication from the examining division (Time limit: M04)
08.10.2002Reply to a communication from the examining division
03.02.2004Despatch of a communication from the examining division (Time limit: M06)
13.07.2004Reply to a communication from the examining division
17.09.2004Despatch of a communication from the examining division (Time limit: M02)
27.10.2004Reply to a communication from the examining division
23.12.2005Communication of intention to grant the patent
25.04.2006Fee for grant paid
25.04.2006Fee for publishing/printing paid
Opposition(s)14.05.2009No opposition filed within time limit [2009/30]
Fees paidRenewal fee
24.01.2002Renewal fee patent year 03
17.04.2003Renewal fee patent year 04
14.06.2004Renewal fee patent year 05
14.06.2005Renewal fee patent year 06
05.06.2006Renewal fee patent year 07
14.06.2007Renewal fee patent year 08
29.04.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9527512  (BAYLOR COLLEGE MEDICINE [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.